Oxford-Amsterdam Winter School – 5th edition!

Suzanne Metselaar, Dept. of Medical Humanities, VU University Medical Center, Amsterdam and Gerben Meynen, Humanities, Dept. of Philosophy, VU University, Amsterdam, and Ruth Horn and Michael Dunn from the Ethox Center, Wellcome Centre for Ethics and Humanities, University of Oxford

Making the transition from being a student to becoming part of an international community of bioethicists can be a challenge. What to expect when participating in conferences? How to critically engage in current bioethical debates? How to bring your point across as convincingly as possible, but to do this in a respectful way, acknowledging the work done by others?

In order to support students in making this transition, we have been organizing an annual Winter School for students of the MA-program Philosophy, Bioethics, and Health (PBH), a two-year MA-program of Philosophy and Medical Humanities, VU University (Medical Center) in Amsterdam. The Winterschool January 2018 was its 5th edition. Continue reading “Oxford-Amsterdam Winter School – 5th edition!”

Advertisements
Oxford-Amsterdam Winter School – 5th edition!

Gene Patents & Access to Health: Speaking at but not to each other

Dr Aisling M. McMahon, Lecturer Newcastle Law School, and our Caroline Miles visiting Scholar in March this year

Recent international developments in gene patenting raise questions again about how bioethical concerns surrounding the grant of patents on health-related technologies are addressed or engaged with by patent law. In 2013 and 2015, the Supreme Court of the United States[1] and the Australian High Court[2], respectively, delivered judgments rejecting the patentability of isolated genes. Both disputes involved Myriad’s patents on BRCA1 and BRCA2 genes. Subsequently, in March 2016 a Canadian case involving the Children’s Hospital of Eastern Ontario’s (CHEO) challenge to patents on genes related to Long QT Syndrome (LQTS) (a condition that can potentially cause irregular and chaotic heartbeats[3]) was settled. The settlement provided a licence to CHEO to test for the syndrome and this has appeared to quell public concerns.[4]

Continue reading “Gene Patents & Access to Health: Speaking at but not to each other”

Gene Patents & Access to Health: Speaking at but not to each other